|
 |
 |
|
 |
 |
28 - 29
MARCH 2008
Perspectives in Central Nervous System Malignancies
IV
Berlin,
Germany
Chairs:
Martin J. van den Bent, MD, PhD
Erasmus University Medical Center
Rotterdam, The Netherlands
W.K. Alfred Yung, MD
MD Anderson Cancer Center
Houston, Texas, United
States
Click
here to register online. |
 |
| F A C U L T Y |
 |
|
Kenneth
D. Aldape, MD
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas, United States
Tracy
Batchelor, MD, MPh
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Brigitta
G. Baumert, MD, PhD
University Hospital Maastricht
Maastricht, The Netherlands
Rolf
Bjerkvig, PhD
University of Bergen
Bergen, Norway
Alba
A. Brandes, MD
Bellaria-Maggiore Hospital
Bologna, Italy
Stuart
A. Grossman, MD
Johns Hopkins University
Baltimore, Maryland, United States
|
David
Jellinek, MD
Royal Hallamshire Hospital
Sheffield, United Kingdom
René-Olivier
Mirimanoff, MD
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
Matthias
Preusser, MD
Medical University of Vienna
Vienna, Austria
Walter
Taal, MD
Erasmus University Medical Center
Rotterdam, The Netherlands
Olaf
van Tellingen, PhD
The Netherlands Cancer Institute
Amsterdam, The Netherlands |
Martin
J. van den Bent, MD, PhD
Congress Chair
Erasmus University Medical Center
Rotterdam, The Netherlands
Stefaan
van Gool, MD, PhD
University Hospital Gastuisberg
Leuven, Belgium
Manfred
Westphal, MD
University Hospital Hamburg-Eppendorf
Hamburg, Germany
W.
K. Alfred Yung, MD
Congress Chair
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas, United States |
|
|
|
S C I E N T I F
I C A G E N D A |
|
|
Friday,
28 March 2008
8:30
Welcome and introduction
Session I: Basic developments in glioma
8:35
 The brain tumor stem cell: Does it exist?
Rolf Bjerkvig, PhD
9:00
Is the blood brain barrier relevant in brain tumor therapy?
Olaf van Tellingen, PhD
9:25
Angiogenesis in glioma progression
Till Acker,MD
9:50
Discussion
10:10
Break
Session II: Diagnosis and prognosis
10:30
Multigene predictor of outcome in glioblastoma
Kenneth D. Aldape, MD
10:55
The tissue factor: Garbage in means garbage out
Pieter Wesseling, MD, PhD
11:20
Pitfalls in response assessment
Martin J. van den Bent, MD, PhD
11:45
Progression free survival as a primary endpoint
Karla V. Ballman, PhD
12:10
Discussion
12:30
Lunch
Session III: Emerging therapies breakout session I
13:30
A: Targeting the PI3 kinase pathway
W.K. Alfred Yung, MD
B: A tale of two trials: Gene therapy
Manfred Westphal, MD
C: Immunotherapy: Alive and kicking?
Stefaan van Gool, MD, PhD
D: Developments in anti-angiogenesis treatment of high grade glioma
Tracy Batchelor, MD, MPH
14:15
Transition
Session IV: Low grade gliomas
14:30
Is there an optimal duration of temozolomide treatment in low grade glioma?
Khê Hoang-Xuan, MD
14:55
The management of low grade and brain stem glioma in children
David A Walker, MD
15:20
Discussion
15:35
Break
Session V: High grade gliomas
15:55
Long term follow-up of the EORTC chemo-irradiation study with temozolomide
René-Olivier Mirimanoff, MD
16:20
Pseudo-progression after radiotherapy and temozolomide: Is it of clinical significance?
Walter Taal, MD
16:45
Is there a clinical relevance of CD4 count and lymphocytopenia?
Stuart A. Grossman, MD
17:10
Discussion
17:25
Adjourn
Satuday,
29 March 2008
8:30
Welcome to day two
Session VI: Recent advances in surgery
8:35
Awake craniotomy in multilingual patients
Gerardo Conesa, MD
9:00
Evaluation of the accuracy of intraoperative 3D ultrasound imaging of intracerebral tumors.
David Jellinek, MD
9:25
Discussion
Session VII: MGMT: Diagnosis and beyond
9:40
Optimal approaches to assessing MGMT expression
Matthias Preusser, MD
10:05
Tumors with unmethylated MGMT promoter: How to improve outcome
Wolfgang Wick, MD
10:30
Discussion
10:45
Break
Session VIII: Emerging therapies breakout session II
11:05
A: Targeting the PI3 kinase pathway
W.K. Alfred Yung, MD
B: A tale of two trials: Gene therapy
Manfred Westphal, MD
C: Immunotherapy: Alive and kicking?
Stefaan van Gool, MD, PhD
D: Developments in anti-angiogenesis treatment of high grade glioma
Tracy Batchelor, MD, MPH
11:50
Transition
Session IX: Controversies in neuro-oncology
12:05
Adjuvant temozolomide: How long? How much?
Alba A. Brandes, MD
12:30
Re-irradiation in recurrent GBM
Brigitta G. Baumert, MD, PhD
12:55
Discussion
13:15
Adjourn
|
|
|
|
W H O S H O U L D A
T T E N D ? |
|
|
This
Congress is intended for neuro-oncologists,
radiation oncologists, neurosurgeons
and other healthcare administrators in
active clinical practice involved and
or interested in CNS tumors and/ or secondary
brain metastases. No specialized knowledge
is required for participation other than
basic familiarity with the principles
of cancer biology and neurobiology. |
|
|
| O
B J E C T I V E S |
|
|
After
successfully completion of this activity,
attendees should be able to:
- Comment
on the latest trends in diagnostics
and prognostics for CNS malignancies
- Discuss
state-of-the-art advancements in neurosurgery
for CNS malignances
- Evaluate
novel treatment strategies and emerging
agents for the management of gliomas
- Describe
the heterogeneity within tumor types
and the key factors to consider when
developing individual patient treatment
plans
- Recognize
controversies associated with the management
of some CNS malignancies
- Develop
a plan for the incorporation of findings
from recent clinical trials into daily
clinical practice, particularly with
regard to the management of gliomas
|
|
|
| A C C R E D I T A T I O N |
|
|
Perspectives
in Central Nervous System Malignancies
IV is accredited by the European Accreditation
Council for Continuing Medical Education
(EACCME) to provide the following CME
activity for medical specialists. The
EACCME is an institution of the European
Union of Medical Specialists (UEMS),
www.uems.net.
Perspectives
in Central Nervous System Malignancies
IV is designated for a maximum of 9 hours
of European external CME credits. Each
medical specialist should claim only
those hours of credit that he/she actually
spent in the educational activity.
EACCME
credits are recognized by the American
Medical Association towards the Physician’s
Recognition Award (PRA). To convert EACCME
credit to AMA PRA category
1 credit, contact the AMA.
|
|
|
|
|
R E G I S T R A T I O N |
|
|
|
Click
here to register online.
Regular
. . . . . . . . . . . . . . . . . . . . € 349
If payment received by 18 March 2008
Full/Onsite
. . . . . . . . . . . . . . . . . . € 449
To register after 18 March 2008
To
Register: You
may register online by 18 March 2008 or
by calling Imedex at +1 (678) 242 0906.
Registration confirmations will be issued
before the Congress.
To
qualify for special registration fees,
registration and full payment must be
received by Imedex by the dates specified.
Payment: To
pre-register, registration and payment
must be received no later than 18 March
2008. Please register onsite after this
date. Contact Imedex at +1 (678) 242
0906 or visit www.imedex.com to ensure the program is being held as
scheduled and to confirm that the meeting
is not full. Registration fees must be
remitted by credit card, check, or wire
transfer. Checks should be payable to Imedex.
To pay via wire transfer, you must add €50
to each wire transaction to cover bank
charges. Include the full name of the attendee
and the name of the Congress: 313 Perspectives
in Central Nervous System Malignancies
IV. An attendee is not registered until
full payment is received
Wire
to: Bank of America, NA London, 1 Alie
Street E1ADE London UK, Swift Code: BOFAGB22,
Sort Code: 165050 Beneficiary: Bank of
America Domestic Deposit #5687,
Account #: 600895687029, Reference: Imedex,
Inc.
Account # 10726-118, IBAN: GB89 BOFA 1650
5095 6870 29.
Registration
Fee Inclusions: Registration fees include
admittance to all scientific sessions,
Congress materials, processing of certificates
of attendance or continuing medical education,
and all event functions as specified
in the program.
Cancellation: For
registration fees to be refunded, written
notice of cancellation must be received
by Imedex at meetings@imedex.com no
later than 18 March 2008. The amount
of registration fees remitted, minus
a €90 administrative
charge, will be refunded after the Congress.
Substitutions are accepted with written
notification. No refunds will be made if
notice is received after 18 March 2008.
Imedex,
LLC does not accept responsibility for covering
travel, accommodation or any other costs
incurred by registrants in the rare event
that this Congress should be canceled for
any reason. Every effort will be made to
give reasonable notice in the event of
cancellation. The event agenda is subject
to change without notice. |
|
|
|
G E N E R A L I
N F O R M A T I O N |
|
|
Important
Dates
Abstract Notifications Mailed
28 February 2008
Abstract
Presenter Registration Deadline
13 March 2008
Regular
Registration Deadline
18 March 2008
Presentation
Dates
28-29 March 2008
Conference
Location and Registration Hours
InterContinental
Berlin
Budapester Straß2 2
10787 Berlin
Germany
Tel.: +49 (0) 30 26 02 12 00
Fax: +49 (0) 30 26 02 26 00
The Registration and Information Desk
will be staffed:
Friday, 28 March 2008 7:30 – 17:25
Saturday, 29 March 2008 7:30 - 13:15
Discounted Airfares:
Contact Congress travel agent, Age of Travel,
for assistance with your travel needs.
Age of Travel can also accommodate pre-
and post-Congress extensions.
Tel.: +1 (800) 523 4954 or +1 (404) 591
7120
Email: imedex@ageoftravel.com
Italian Participants
Fargo International Meetings & Conventions SRL has been appointed as the
official agency for government authorization for Italian participants.
You
may contact them directly at:
Fargo International Meetings & Conventions SRL
Via Piattro Maroncelli 44/66, 50137 Firenze,
Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078 |
|
|
|
H O T E L A C
C O M M O D A T I O N S |
|
|
| InterContinental
Berlin
Budapester Straß2 2
10787 Berlin
Germany
Tel.: +49 (0) 30 26 02 12 00
Fax: +49 (0) 30 26 02 26 00
www.berlin.intercontinental.com
To reserve a room call the hotel or click
here.
The
InterContinental Berlin has struck an
impressive pose on the city skyline for
nearly half a century. A better location
is hard to imagine, with the government
quarter, historic centre, shopping districts
and Berlin’s important
sites just minutes away.
A
short walk will take you to Kurfürstendamm
Boulevard and the Potsdamer Platz. Discover
Berlin Cathedral, the famous Memorial Church,
the Brandenburg Gate or the Victory Column.
Visit the National Gallery or one of Berlin's
numerous museums. Go shopping at the KaDeWe
or at Friedrichstrasse or just promenade
around the fascinating Gendarmen Markt.
Go jogging or take a walk in the Tiergarten
park nearby.
For
the convenience of attendees, a limited
number of rooms have been reserved until
6 March 2008 at discounted rates starting
at €150 single occupancy
and €170
double occupancy. These rates include a
breakfast buffet. This rate is not guaranteed
outside the Congress dates or after 6
March 2008.
To
reserve your room please contact the
InterContinental Berlin reservations
department at +49 (0) 30 26 02 12 00.
To receive the group rate, callers must
identify themselves as being with the
Perspectives in Central Nervous System
Malignancies IV group. Reservation requests
received after 6 March 2008 may not be
guaranteed the group rate. |
|
|
|
O R G A N I Z E R |
|
|
|
|
©
2008 Imedex®, LLC |
|
